PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17186014-7	2007	Increased transgene expression following infection with an adenovirus expressing tumor necrosis factor-related apoptosis inducing ligand (TRAIL) was observed only in LNCaP cells treated with depsipeptide or MS-275.	Depsipeptides	191-203	TNF superfamily member 10	Homo sapiens	81-136	
17186014-7	2007	Increased transgene expression following infection with an adenovirus expressing tumor necrosis factor-related apoptosis inducing ligand (TRAIL) was observed only in LNCaP cells treated with depsipeptide or MS-275.	Depsipeptides	191-203	TNF superfamily member 10	Homo sapiens	138-143	
16849582-0	2006	Bortezomib and depsipeptide sensitize tumors to tumor necrosis factor-related apoptosis-inducing ligand: a novel method to potentiate natural killer cell tumor cytotoxicity.	Depsipeptides	15-27	TNF superfamily member 10	Homo sapiens	48-103	
15771957-0	2005	Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.	Depsipeptides	0-12	TNF superfamily member 10	Homo sapiens	59-64	
15771957-0	2005	Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts.	Depsipeptides	0-12	TNF superfamily member 10	Homo sapiens	83-88	
15771957-5	2005	Thus, studies were initiated to evaluate the ability of depsipeptide to enhance the cytotoxic activity of Ad5-TRAIL against human prostate tumor cells.	Depsipeptides	56-68	TNF superfamily member 10	Homo sapiens	110-115	
15771957-7	2005	Additionally, tumor cell killing by Ad5-TRAIL was higher following depsipeptide pretreatment.	Depsipeptides	67-79	TNF superfamily member 10	Homo sapiens	40-45	
15771957-9	2005	Investigation into the mechanism responsible for increased TRAIL responsiveness revealed increased levels of TRAIL-R1 and -R2 in membrane lipid rafts following depsipeptide treatment.	Depsipeptides	160-172	TNF superfamily member 10	Homo sapiens	59-64	
15771957-10	2005	These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy.	Depsipeptides	28-40	TNF superfamily member 10	Homo sapiens	93-98	
15771957-10	2005	These results indicate that depsipeptide is a potent agent for enhancing the activity of Ad5-TRAIL by multiple mechanisms, allowing for a more efficient use of Ad5-TRAIL as an antitumor therapy.	Depsipeptides	28-40	TNF superfamily member 10	Homo sapiens	164-169	
15608694-4	2004	We report that low concentrations of histone deacetylase (HDAC) inhibitors, such as depsipeptide, which alone failed to induce apoptosis, markedly sensitize CLL cells and other primary lymphoid malignancies to TRAIL-induced apoptosis.	Depsipeptides	84-96	TNF superfamily member 10	Homo sapiens	210-215